Macclesfield, United Kingdom

Martin Pass

USPTO Granted Patents = 6 

Average Co-Inventor Count = 2.8

ph-index = 5

Forward Citations = 41(Granted Patents)


Location History:

  • StockPort, GB (2002 - 2003)
  • Stevenage, GB (2002 - 2006)
  • Macclesfield, GB (2004 - 2011)

Company Filing History:


Years Active: 2002-2011

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Martin Pass: Innovator in Pharmaceutical Chemistry

Introduction

Martin Pass is a distinguished inventor located in Macclesfield, GB, with a remarkable portfolio of six patents. His innovative contributions primarily focus on the development of pharmaceutical compounds aimed at treating various medical conditions, particularly cancer and inflammatory diseases.

Latest Patents

Among Martin's latest patents, two stand out for their significant potential in the pharmaceutical industry. The first patent involves 2,4,6-trisubstituted pyrimidines as phosphatidylinositol (PI) 3-kinase inhibitors, which are instrumental in treating cancer. This invention details pyrimidine derivatives of a specific formula, outlining processes for their preparation and their formulation into pharmaceutical compositions that can induce an anti-proliferative effect in warm-blooded animals, including humans.

His second notable patent describes substituted pyrimidines as selective cyclooxygenase-2 inhibitors. The invention presents compounds designed to be potent and selective COX-2 inhibitors, useful in treating pain, fever, and inflammation associated with a variety of diseases. The specified compound formula and its derivatives hold great promise for developing effective therapeutic agents.

Career Highlights

Throughout his career, Martin has significantly contributed to the pharmaceutical field, with notable positions at leading companies such as SmithKline Beecham Corporation and AstraZeneca. His work in these organizations has allowed him to collaborate on various innovative projects that have advanced drug development in the industry.

Collaborations

Martin's career has been enriched by his collaborations with skilled professionals like David E Bays and Richard Peter Charles Cousins. Working alongside such talented colleagues has facilitated the exchange of ideas and enhanced the quality of innovations produced.

Conclusion

Martin Pass continues to be an influential figure in pharmaceutical chemistry, with a focused dedication to developing new treatments for cancer and inflammatory diseases. His patents reflect his commitment to innovation and the potential impact of his work in improving health outcomes. With each development, Martin is paving the way for future advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…